| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $616K | +29.8% |
| SG&A Expense | $1.3M | +70.2% |
| Operating Income | -$13.7M | -97.1% |
| Pre-tax Income | -$12.9M | -93.8% |
| Net Income | -$12.9M | -93.8% |
| EPS (Basic) | -$0.71 | -7.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -70.8% |
| Current Assets | $2.9M | -64.1% |
| Total Assets | $21.8M | +85.7% |
| Current Liabilities | $5.4M | +134.5% |
| Long-term Debt | $11.1M | — |
| Total Liabilities | $11.3M | +200.2% |
| Stockholders' Equity | $10.5M | +31.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | -135.1% |
| Investing Cash Flow | -$640K | +36.4% |
| Financing Cash Flow | $7.6M | -43.6% |